Litigation Update: Risperdal Verdict

Last week a jury in Philadelphia hit Johnson & Johnson and its Janssen Pharmaceuticals subsidiary with an $8 billion punitive damages verdict in a Risperdal trial. Nicholas Murray’s lawsuit alleged that, after being given Risperdal in 2003 at age nine for symptoms of autism, he grew breast tissue, a condition known as gynecomastia. J&J was accused of failing to warn about the risks of Risperdal and improperly marketing it to treat certain mental health conditions in children. Risperdal is an anti-psychotic drug approved by the FDA for schizophrenia in adults in the 1990s. In October 2006 the FDA approved a pediatric application for the drug to treat symptoms of autism in children.

A jury had previously awarded Murray $1.75 million in compensatory damages, finding that warning labels at the time he used the drug failed to adequately warn doctors about the risk of abnormal breast growth in adolescents. That award was later reduced to $680,000 due to a cap on non-economic damages under Maryland law. At the time, the jury was prevented from considering a punitive damage award due to a global order in the mass tort program established to coordinate the approximately 7,000 Risperdal cases pending in Philadelphia County. That order was overturned on appeal, allowing the punitive damages phase to proceed.

In 2013, Johnson & Johnson paid $2.2 billion in criminal and civil fines, in part to resolve allegations that it illegally marketed Risperdal as a way to control patients with dementia in nursing homes and children with certain behavioral disabilities.

Click on this link for information on Verus’ Case Management and Medical Review Services. To contact us, fill out this form or email us at and we will reply immediately.

READ  Litigation Update: Talc Lawsuits Developments for Chanel, L’Oreal and Imerys


V.P. of Mass Torts Services, General Counsel

Deb is a lawyer with over 25 years of legal and business experience. As the leader of mass tort services at Verus, she oversees the support services provided to law firms involved in mass tort litigation, specifically in the areas of case management, claimant contact and medical record review. More

Spread the love

Author: Edward Lott

Edward Lott, Ph.D., M.B.A. is President and Managing Partner of Allentown-based ForLawFirmsOnly Marketing, Inc., a client acquisition company that offers attorneys signed client cases.Ed has been a digital entrepreneur since 1994, having discovered very early the opportunities the Internet offered. After having spent over two decades helping small business owners, Ed joined the staff of ForLawFirmsOnly Marketing as President and Managing Partner, where he is expanding the agency's cutting-edge services.A true marketing futurist, Ed's vast experience working directly with attorneys has given him a unique perspective on law firm marketing not found in many other digital marketing agencies. Ed has reshaped the offerings of ForLawFirmsOnly to focus on growing law firms through a holistic approach to digital marketing evident in the reformulated lead generation processes now in place. He is taking that same holistic approach for small businesses, helping them grow their bottom line.Want to learn more about ForLawFirmsOnly Marketing, our client acquistion services or lead generation programs, or just talk to Ed about his visions for helping your business grow? Call him at 855-943-8736.

Copyright ©2021 Medical Injury Help, ForLawFirmsOnly Marketing, Inc. All Rights Reserved